Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Progyny, Inc. Director's Dealing 2021

Dec 3, 2021

31752_dirs_2021-12-03_fa78999e-793e-4760-827c-30c50bf8bd12.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Progyny, Inc. (PGNY)
CIK: 0001551306
Period of Report: 2021-12-01

Reporting Person: Payson Norman (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-12-01 Common Stock M 225000 $1.45 Acquired 233652 Direct
2021-12-01 Common Stock S 2097 $48.24 Disposed 570229 Indirect
2021-12-01 Common Stock S 2233 $49.42 Disposed 567996 Indirect
2021-12-01 Common Stock S 1200 $50.68 Disposed 566796 Indirect
2021-12-01 Common Stockq S 1402 $51.54 Disposed 565394 Indirect
2021-12-01 Common Stock S 1398 $52.24 Disposed 563996 Indirect
2021-12-02 Common Stock S 5046 $48.47 Disposed 558950 Indirect
2021-12-02 Common Stock S 2984 $49.19 Disposed 555966 Indirect
2021-12-02 Common Stock S 300 $50.26 Disposed 555666 Indirect

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-12-01 Stock Option (right to buy) $1.45 M 225000 Disposed 2026-12-07 Common Stock (225000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 122493 Indirect

Footnotes

F1: Adjusted due to rounding error.

F2: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on June 21, 2021.

F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.91 to $47.58, inclusive.

F4: The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3), (6), (7), (8), (9), (10), (11) and (12).

F5: The reportable securities are directly held by Norman C. Payson and Melinda B. Payson, Trustees of The Norman C. and Melinda B. Payson Revocable Trust.

F6: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.99 to $49.86, inclusive.

F7: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.15 to $51.12, inclusive.

F8: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.17 to $52.155, inclusive.

F9: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.165 to $52.4, inclusive.

F10: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.89 to 48.87, inclusive.

F11: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.9 to $49.885, inclusive.

F12: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.2 to $50.33, inclusive.

F13: The reportable securities are directly held by EVO Eagle, LLC. The Reporting Person shares voting and dispositive power over the securities.

F14: One forty-eighth (1/48th) of the shares subject to the Option vested or shall vest each month commencing January 2, 2017, subject to the Reporting Person continuing to provide service through each such date.